These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8122821)

  • 21. [Fc gamma receptors. Properties and participation in IgG binding and other biological processes].
    Sokal I
    Postepy Hig Med Dosw; 1995; 49(1):47-51. PubMed ID: 8657617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
    Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
    Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.
    Omtvedt LA; Royle L; Husby G; Sletten K; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM
    Arthritis Rheum; 2006 Nov; 54(11):3433-40. PubMed ID: 17075835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin.
    Tsuchiya N; Endo T; Matsuta K; Yoshinoya S; Takeuchi F; Nagano Y; Shiota M; Furukawa K; Kochibe N; Ito K
    J Immunol; 1993 Jul; 151(2):1137-46. PubMed ID: 8335895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG glycosylation analysis.
    Huhn C; Selman MH; Ruhaak LR; Deelder AM; Wuhrer M
    Proteomics; 2009 Feb; 9(4):882-913. PubMed ID: 19212958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum.
    Wuhrer M; Stam JC; van de Geijn FE; Koeleman CA; Verrips CT; Dolhain RJ; Hokke CH; Deelder AM
    Proteomics; 2007 Nov; 7(22):4070-81. PubMed ID: 17994628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine.
    Bond A; Alavi A; Axford JS; Bourke BE; Bruckner FE; Kerr MA; Maxwell JD; Tweed KJ; Weldon MJ; Youinou P; Hay FC
    J Autoimmun; 1997 Feb; 10(1):77-85. PubMed ID: 9080302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
    Newkirk MM; LePage K; Niwa T; Rubin L
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis.
    Nandakumar KS; Collin M; Olsén A; Nimmerjahn F; Blom AM; Ravetch JV; Holmdahl R
    Eur J Immunol; 2007 Oct; 37(10):2973-82. PubMed ID: 17899548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis.
    Bonagura VR; Agostino N; Børretzen M; Thompson KM; Natvig JB; Morrison SL
    J Immunol; 1998 Mar; 160(5):2496-505. PubMed ID: 9498795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interview with Jean-François Borel. What is going to happen tomorrow in the field of cyclosporine?].
    Borel JF
    Ann Med Interne (Paris); 1995; 146(4):251-3. PubMed ID: 7653946
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycosylation of human IgG subclass and mouse IgG2b heavy chains secreted by mouse J558L transfectoma cell lines as chimeric antibodies.
    Lund J; Takahashi N; Hindley S; Tyler R; Goodall M; Jefferis R
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):20-5. PubMed ID: 8431554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interview with Gilbert Faure and Marie-Christine Béné: what is going to happen tomorrow in leukemia immunophenotyping?].
    Faure G; Béné MC
    Ann Med Interne (Paris); 1996; 147(6):408-10. PubMed ID: 9092344
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interview with Gilbert Fournié. What is going to happen tomorrow in the field of physiopathology of systemic lupus erythematosus?].
    Fournié G
    Ann Med Interne (Paris); 1996; 147(5):320-5. PubMed ID: 9033733
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interview with Moncef Zouali: What is going to happen tomorrow in the field of lupus anti-DNA antibodies?].
    Zouali M
    Ann Med Interne (Paris); 1995; 146(5):316-8. PubMed ID: 8526316
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice.
    Millward TA; Heitzmann M; Bill K; Längle U; Schumacher P; Forrer K
    Biologicals; 2008 Jan; 36(1):41-7. PubMed ID: 17890101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An increased level of the Concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA).
    Klaamas K; Kodar K; Kurtenkov O
    Neoplasma; 2008; 55(2):143-50. PubMed ID: 18237253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig.
    Eklund EA; Newell JW; Sun L; Seo NS; Alper G; Willert J; Freeze HH
    Mol Genet Metab; 2005 Jan; 84(1):25-31. PubMed ID: 15639192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
    Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
    J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.